EuroIntervention PCRonline - Connecting with the community

Just accepted article

Complete or incomplete coronary revascularization in patients with myocardial infarction and multivessel disease. A propensity score analysis from the "real life" BleeMACS (Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome) registry.

Disclaimer:

As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers. To read the full content of this article, please download the PDF.

Sign in to download the full article

1. ITALY; 2. Dipartimento di Scienze Mediche, Divisione di Cardiologia, Città della Salute e della Scienza, Turin, Italy; 3. Dipartimento di Scienze Mediche, Divisione di Cardiologia, Città della Salute e della Scienza, Turin, Italy; 4. Dipartimento di Scienze Mediche, Divisione di Cardiologia, Città della Salute e della Scienza, Turin, Italy; 5. University Hospital Álvaro Cunqueiro, Vigo, Spain.; 6. University Hospital Álvaro Cunqueiro, Vigo, Spain; 7. University Academic Medical Center, Amsterdam.; 8. NorthShore University Hospital, Chicago; 9. University Clinical Hospital of Santiago de Compostela, Spain.; 10. Libin Cardiovascular Institute of Alberta, Calgary; 11. University Academic Medical Center, Amsterdam; 12. San Carlos Hospital, Madrid; 13. Bellvitge Hospital, Barcelona; 14. Beijing Anzhen Hospital, Capital Medical University, Beijing; 15. University Patras Hospital, Athens; 16. Kerckhoff Heart and Thorax Center, Frankfurt; 17. University Clinical Hospital, Kyoto; 18. University Clinical Hospital, Warsaw; 19. Institute of Heart, Lung and Blood Vessel Disease, Beijing; 20. Tokai University School of Medicine, Tokyo; 21. Hospital Sao Rafael, Salvador; 22. Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa; 23. University Hospital Álvaro Cunqueiro, Vigo, Spain; 24. Libin Cardiovascular Institute of Alberta, Calgary; 25. San Carlos Hospital, Madrid; 26. San Carlos Hospital, Madrid; 27. Bellvitge Hospital, Barcelona; 28. Beijing Anzhen Hospital, Capital Medical University, Beijing; 29. Beijing Anzhen Hospital, Capital Medical University, Beijing; 30. University Patras Hospital, Athens; 31. Kerckhoff Heart and Thorax Center, Frankfurt; 32. Kerckhoff Heart and Thorax Center, Frankfurt; 33. University Clinical Hospital, Kyoto; 34. Dipartimento di Scienze Mediche, Divisione di Cardiologia, Città della Salute e della Scienza, Turin, Italy; 35. Dipartimento di Scienze Mediche, Divisione di Cardiologia, Città della Salute e della Scienza, Turin, Italy; 36. Dipartimento di Scienze Mediche, Divisione di Cardiologia, Città della Salute e della Scienza, Turin, Italy; 37. Dipartimento di Scienze Mediche, Divisione di Cardiologia, Città della Salute e della Scienza, Turin, Italy; 38. University Clinical Hospital, Warsaw; 39. University Clinical Hospital, Warsaw; 40. Institute of Heart, Lung and Blood Vessel Disease, Beijing; 41. Institute of Heart, Lung and Blood Vessel Disease, Beijing; 42. Institute of Heart, Lung and Blood Vessel Disease, Beijing; 43. Tokai University School of Medicine, Tokyo; 44. Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa; 45. Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa; 46. Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa; 47. University Clinic of Cardiology, Skopje; 48. University Clinic of Cardiology, Skopje; 49. S.C. Cardiologia, Ospedale degli Infermi, Rivoli, Torino; 50. Dipartimento di Scienze Mediche, Divisione di Cardiologia, Città della Salute e della Scienza, Turin, Italy

Abstract

Background: The benefit of complete or incomplete percutaneous coronary intervention (PCI) in patients with myocardial infarction and multivessel disease remains debated.

Methods: We conducted a multicenter study including all patients with myocardial infarction and multivessel coronary disease included in the BleeMACS (Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome) registry. They were divided in two groups: Complete revascularization (CR) and Incomplete Revascularization (IR). Primary endpoint was death rate at one-year follow-up. Secondary endpoints were in-hospital…

– OR –